We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

93 hedge funds and large institutions have $910M invested in Takeda Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 93 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $7.49M | Put options by funds: $4.34M

6.8% more ownership

Funds ownership: 0% → 6.8% (+6.8%)

Holders
93
Holders Change
+93
Holders Change %
–
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
93
Increased
–
Reduced
–
Closed
–
Calls
$7.49M
Puts
$4.34M
Net Calls
+$3.14M
Net Calls Change
+$3.14M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$171M
2
Bank of America
Bank of America
North Carolina
+$116M
3
Citigroup
Citigroup
New York
+$111M
4
Goldman Sachs
Goldman Sachs
New York
+$86.2M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$63.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
76
Geneos Wealth Management
Colorado
$6K +$6.14K +364 New
GI
77
Gradient Investments
Minnesota
$5K +$4.83K +286 New
AWM
78
AllSquare Wealth Management
New York
$5K +$5.2K +308 New
CAW
79
Cornerstone Advisors (Washington)
Washington
$5K +$5.5K +326 New
Carson Wealth (CWM LLC)
80
Carson Wealth (CWM LLC)
Nebraska
$4K +$3.75K +222 New
AIA
81
Alera Investment Advisors
Illinois
$4K +$4.25K +252 New
GT
82
Glenmede Trust
Pennsylvania
$3.67K +$3.68M +218,085 New
BlackRock
83
BlackRock
New York
$3K +$3.04K +180 New
RCAG
84
Rehmann Capital Advisory Group
Michigan
$2.79K +$2.8K +166 New
WAM
85
Wealthspire Advisors (Maryland)
Maryland
$1K +$591 +35 New
SWM
86
SeaCrest Wealth Management
New York
$1K +$658 +39 New
Fifth Third Bancorp
87
Fifth Third Bancorp
Ohio
$1K +$743 +44 New
Fidelity Investments
88
Fidelity Investments
Massachusetts
$1K +$1.35K +80 New
AC
89
Avestar Capital
New York
$1K +$1.37K +81 New
TL
90
TrueWealth LLC
Georgia
$1K +$1.42K +84 New
EFSCE
91
Enterprise Financial Services Corp (EFSC)
Missouri
– +$169 +10 New
SWP
92
Strategic Wealth Partners
Ohio
– +$253 +15 New
BBHC
93
Brown Brothers Harriman & Co
New York
– +$490 +29 New
1 2 3
4

TAK Hedge Fund Activity: Q4 2018 in Review

93 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q4 2018, worth a combined $910M.

Buyers outnumbered sellers: 93 funds opened new TAK positions and 0 closed out — a net gain of 93 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $171M.

  • 93 institutional investors held Takeda Pharmaceutical (TAK) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $910M of Takeda Pharmaceutical stock for Q4 2018.
  • 93 funds opened new Takeda Pharmaceutical positions in Q4 2018 and 0 closed out, a net change of +93 holders.
  • The largest Takeda Pharmaceutical buyer in Q4 2018 was UBS Group, an estimated $171M added.

Based on aggregated 13F filings for Q4 2018.